phenmetrazine has been researched along with Coronary Disease in 1 studies
Phenmetrazine: A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to DEXTROAMPHETAMINE.
phenmetrazine : A member of the class of morpholines that is morpholine substituted with a phenyl group at position 2 and a methyl group at position 3.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HOWARD, LA | 1 |
| KLEIN, HT | 1 |
| BERK, MS | 1 |
1 other study available for phenmetrazine and Coronary Disease
| Article | Year |
|---|---|
COMPLICATED OBESITY: CLINICAL EVALUATION OF A TIMED-RELEASE ANORECTIC AGENT.
Topics: Appetite Depressants; Biomedical Research; Coronary Disease; Delayed-Action Preparations; Diabetes M | 1964 |